List of Tables
Table 1. Global Point-of-care Testing (POCT) for Inflammatory Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Point-of-care Testing (POCT) for Inflammatory Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Point-of-care Testing (POCT) for Inflammatory Market Competitive Situation by Manufacturers in 2024
Table 4. Global Point-of-care Testing (POCT) for Inflammatory Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Inflammatory Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Inflammatory Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Point-of-care Testing (POCT) for Inflammatory Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Point-of-care Testing (POCT) for Inflammatory, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Point-of-care Testing (POCT) for Inflammatory, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Point-of-care Testing (POCT) for Inflammatory, Product Type & Application
Table 12. Global Key Manufacturers of Point-of-care Testing (POCT) for Inflammatory, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-of-care Testing (POCT) for Inflammatory by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Inflammatory as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Point-of-care Testing (POCT) for Inflammatory Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Point-of-care Testing (POCT) for Inflammatory Sales by Region (2020-2025) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Region (2020-2025)
Table 19. Global Point-of-care Testing (POCT) for Inflammatory Sales by Region (2026-2031) & (K Units)
Table 20. Global Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Region (2026-2031)
Table 21. Global Point-of-care Testing (POCT) for Inflammatory Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Region (2020-2025)
Table 23. Global Point-of-care Testing (POCT) for Inflammatory Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Region (2026-2031)
Table 25. North America Point-of-care Testing (POCT) for Inflammatory Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Point-of-care Testing (POCT) for Inflammatory Sales by Country (2020-2025) & (K Units)
Table 27. North America Point-of-care Testing (POCT) for Inflammatory Sales by Country (2026-2031) & (K Units)
Table 28. North America Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Point-of-care Testing (POCT) for Inflammatory Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Point-of-care Testing (POCT) for Inflammatory Sales by Country (2020-2025) & (K Units)
Table 32. Europe Point-of-care Testing (POCT) for Inflammatory Sales by Country (2026-2031) & (K Units)
Table 33. Europe Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Point-of-care Testing (POCT) for Inflammatory Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Point-of-care Testing (POCT) for Inflammatory Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Point-of-care Testing (POCT) for Inflammatory Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Point-of-care Testing (POCT) for Inflammatory Sales (K Units) by Type (2020-2025)
Table 51. Global Point-of-care Testing (POCT) for Inflammatory Sales (K Units) by Type (2026-2031)
Table 52. Global Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Type (2020-2025)
Table 53. Global Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Type (2026-2031)
Table 54. Global Point-of-care Testing (POCT) for Inflammatory Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Inflammatory Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Type (2020-2025)
Table 57. Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Type (2026-2031)
Table 58. Global Point-of-care Testing (POCT) for Inflammatory Price (US$/Unit) by Type (2020-2025)
Table 59. Global Point-of-care Testing (POCT) for Inflammatory Price (US$/Unit) by Type (2026-2031)
Table 60. Global Point-of-care Testing (POCT) for Inflammatory Sales (K Units) by Application (2020-2025)
Table 61. Global Point-of-care Testing (POCT) for Inflammatory Sales (K Units) by Application (2026-2031)
Table 62. Global Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Application (2020-2025)
Table 63. Global Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Application (2026-2031)
Table 64. Global Point-of-care Testing (POCT) for Inflammatory Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Point-of-care Testing (POCT) for Inflammatory Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Application (2020-2025)
Table 67. Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Application (2026-2031)
Table 68. Global Point-of-care Testing (POCT) for Inflammatory Price (US$/Unit) by Application (2020-2025)
Table 69. Global Point-of-care Testing (POCT) for Inflammatory Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Point-of-care Testing (POCT) for Inflammatory Product
Table 74. Roche Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Point-of-care Testing (POCT) for Inflammatory Product
Table 79. Abbott Recent Developments/Updates
Table 80. Siemens Healthineers Company Information
Table 81. Siemens Healthineers Description and Business Overview
Table 82. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Product
Table 84. Siemens Healthineers Recent Developments/Updates
Table 85. BioMerieux Company Information
Table 86. BioMerieux Description and Business Overview
Table 87. BioMerieux Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. BioMerieux Point-of-care Testing (POCT) for Inflammatory Product
Table 89. BioMerieux Recent Developments/Updates
Table 90. Bio-Rad Laboratories Company Information
Table 91. Bio-Rad Laboratories Description and Business Overview
Table 92. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Product
Table 94. Bio-Rad Laboratories Recent Developments/Updates
Table 95. Assure Tech Company Information
Table 96. Assure Tech Description and Business Overview
Table 97. Assure Tech Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Assure Tech Point-of-care Testing (POCT) for Inflammatory Product
Table 99. Assure Tech Recent Developments/Updates
Table 100. Guangzhou Wondfo Biotech Co.,Ltd. Company Information
Table 101. Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
Table 102. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product
Table 104. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 105. Wuhan Easy Diagnosis Company Information
Table 106. Wuhan Easy Diagnosis Description and Business Overview
Table 107. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Product
Table 109. Wuhan Easy Diagnosis Recent Developments/Updates
Table 110. Getein Biotech Company Information
Table 111. Getein Biotech Description and Business Overview
Table 112. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Product
Table 114. Getein Biotech Recent Developments/Updates
Table 115. Beijing Hotgen Biotech Co.,ltd. Company Information
Table 116. Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
Table 117. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Product
Table 119. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 120. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Company Information
Table 121. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Description and Business Overview
Table 122. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Product
Table 124. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
Table 125. Qingdao Hightop Biotech Co., Ltd. Company Information
Table 126. Qingdao Hightop Biotech Co., Ltd. Description and Business Overview
Table 127. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Product
Table 129. Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
Table 130. Goldsite Diagnostics Inc. Company Information
Table 131. Goldsite Diagnostics Inc. Description and Business Overview
Table 132. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Product
Table 134. Goldsite Diagnostics Inc. Recent Developments/Updates
Table 135. Genrui Biotech Inc Company Information
Table 136. Genrui Biotech Inc Description and Business Overview
Table 137. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Product
Table 139. Genrui Biotech Inc Recent Developments/Updates
Table 140. Hipro Biotechnology CO.,LTD Company Information
Table 141. Hipro Biotechnology CO.,LTD Description and Business Overview
Table 142. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Product
Table 144. Hipro Biotechnology CO.,LTD Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Point-of-care Testing (POCT) for Inflammatory Distributors List
Table 148. Point-of-care Testing (POCT) for Inflammatory Customers List
Table 149. Point-of-care Testing (POCT) for Inflammatory Market Trends
Table 150. Point-of-care Testing (POCT) for Inflammatory Market Drivers
Table 151. Point-of-care Testing (POCT) for Inflammatory Market Challenges
Table 152. Point-of-care Testing (POCT) for Inflammatory Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Point-of-care Testing (POCT) for Inflammatory
Figure 2. Global Point-of-care Testing (POCT) for Inflammatory Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Testing (POCT) for Inflammatory Market Share by Type: 2024 & 2031
Figure 4. Based on Immunochromatography Product Picture
Figure 5. Based on Chemiluminescence Product Picture
Figure 6. Based on Microfluidic Chip Product Picture
Figure 7. Global Point-of-care Testing (POCT) for Inflammatory Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Point-of-care Testing (POCT) for Inflammatory Market Share by Application: 2024 & 2031
Figure 9. C-Reactive Protein (CRP) Test
Figure 10. Procalcitonin (PCT) Test
Figure 11. Interleukin 6 (IL-6) Test
Figure 12. Serum amyloid A (SAA) Test
Figure 13. Others
Figure 14. Global Point-of-care Testing (POCT) for Inflammatory Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Point-of-care Testing (POCT) for Inflammatory Market Size (2020-2031) & (US$ Million)
Figure 16. Global Point-of-care Testing (POCT) for Inflammatory Sales (2020-2031) & (K Units)
Figure 17. Global Point-of-care Testing (POCT) for Inflammatory Average Price (US$/Unit) & (2020-2031)
Figure 18. Point-of-care Testing (POCT) for Inflammatory Report Years Considered
Figure 19. Point-of-care Testing (POCT) for Inflammatory Sales Share by Manufacturers in 2024
Figure 20. Global Point-of-care Testing (POCT) for Inflammatory Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Point-of-care Testing (POCT) for Inflammatory Players: Market Share by Revenue in Point-of-care Testing (POCT) for Inflammatory in 2024
Figure 22. Point-of-care Testing (POCT) for Inflammatory Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Point-of-care Testing (POCT) for Inflammatory Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Country (2020-2031)
Figure 25. North America Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Country (2020-2031)
Figure 26. United States Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Country (2020-2031)
Figure 29. Europe Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Country (2020-2031)
Figure 30. Germany Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Region (2020-2031)
Figure 37. China Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Country (2020-2031)
Figure 45. Latin America Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Point-of-care Testing (POCT) for Inflammatory Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Point-of-care Testing (POCT) for Inflammatory by Type (2020-2031)
Figure 55. Global Revenue Market Share of Point-of-care Testing (POCT) for Inflammatory by Type (2020-2031)
Figure 56. Global Point-of-care Testing (POCT) for Inflammatory Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Point-of-care Testing (POCT) for Inflammatory by Application (2020-2031)
Figure 58. Global Revenue Market Share of Point-of-care Testing (POCT) for Inflammatory by Application (2020-2031)
Figure 59. Global Point-of-care Testing (POCT) for Inflammatory Price (US$/Unit) by Application (2020-2031)
Figure 60. Point-of-care Testing (POCT) for Inflammatory Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
